Ginkgo Bioworks Holdings, Inc. short interest in 2024
In 2024, Ginkgo Bioworks Holdings, Inc.'s disclosed short interest ran from 11.04% of shares outstanding on 12 Jan 2024 to 12.83% on 31 Dec 2024, a change of +1.79 percentage points. The year's high was 13.46% on 30 Apr 2024 and its low 4.40% on 15 Jul 2024, averaging 10.84% across 20 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 16.88 days on 28 Mar 2024. Full history: Ginkgo Bioworks Holdings, Inc..
Cite this page
By year: 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 11.04% (12 Jan 2024)
- End of year
- 12.83% (31 Dec 2024)
- Change
- +1.79 pp
- High
- 13.46% (30 Apr 2024)
- Low
- 4.40% (15 Jul 2024)
- Average
- 10.84%
- Highest days to cover
- 16.88 (28 Mar 2024)
- SEC filings marked
- 8
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 11.04% | 10.21 | results (8-K) |
| 31 Jan 2024 | 11.18% | 10.52 | |
| 15 Feb 2024 | 11.81% | 11.66 | |
| 29 Feb 2024 | 11.88% | 12.34 | 10-K filed, results (8-K) |
| 15 Mar 2024 | 12.18% | 8.51 | |
| 28 Mar 2024 | 12.58% | 16.88 | |
| 15 Apr 2024 | 12.38% | 11.58 | |
| 30 Apr 2024 | 13.46% | 5.39 | |
| 15 May 2024 | 12.41% | 4.26 | 10-Q filed, results (8-K) |
| 31 May 2024 | 11.10% | 4.80 | |
| 14 Jun 2024 | 10.77% | 6.92 | |
| 28 Jun 2024 | 5.48% | 1.10 | |
| 15 Jul 2024 | 4.40% | 1.82 | |
| 31 Jul 2024 | 5.58% | 2.87 | |
| 15 Aug 2024 | 6.90% | 3.16 | 10-Q filed |
| 31 Oct 2024 | 12.75% | 8.59 | |
| 15 Nov 2024 | 12.73% | 5.14 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 12.90% | 7.15 | |
| 13 Dec 2024 | 12.48% | 4.61 | |
| 31 Dec 2024 | 12.83% | 5.02 |
See also: Ginkgo Bioworks Holdings, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.